J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India flag India · Delayed Price · Currency is INR
2,188.80
-37.65 (-1.69%)
At close: May 26, 2026

BOM:506943 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1,4591,151882.15769.34565.44
Short-Term Investments
7,389178.9267.70.851.06
Trading Asset Securities
-3,1713,6471,922-
Cash & Short-Term Investments
8,8484,5014,5962,692566.5
Cash Growth
96.58%-2.08%70.74%375.20%-91.83%
Accounts Receivable
7,8098,1546,8695,7585,557
Other Receivables
-95.76160.06275.92411.27
Receivables
7,8158,2557,0366,0485,981
Inventory
6,8345,2905,0254,3054,100
Prepaid Expenses
-190.14163.23167.05120.4
Other Current Assets
5,597991.771,7132,0691,764
Total Current Assets
29,09419,22718,53315,28012,532
Property, Plant & Equipment
6,7286,5666,3495,7645,668
Long-Term Investments
260.32,784285.13137.84127.22
Goodwill
574.59574.59574.59574.59574.59
Other Intangible Assets
12,29113,17113,88513,2236,714
Long-Term Deferred Tax Assets
68.7384.1958.7865.164.31
Other Long-Term Assets
668.1326.35250.14486.97386.74
Total Assets
49,68642,73839,94135,53926,074
Accounts Payable
3,9104,1073,5632,3862,245
Accrued Expenses
-202.33167.83176.15247.43
Short-Term Debt
-138.04153.43280.18263.15
Current Portion of Long-Term Debt
--3,1821,370-
Current Portion of Leases
24.6577.33108.7788.8776.26
Current Income Taxes Payable
92.0582.3117.6249.5460.95
Current Unearned Revenue
-10.8412.1911.8317.06
Other Current Liabilities
1,8851,7051,3781,181927.51
Total Current Liabilities
5,9126,3238,6825,5443,837
Long-Term Debt
--236.393,832-
Long-Term Leases
11.2563.5396.38153.21206.18
Long-Term Unearned Revenue
35.8219.0116.9924.9331.66
Pension & Post-Retirement Benefits
-3.390.626.015.12
Long-Term Deferred Tax Liabilities
1,8421,7731,4921,028475.59
Other Long-Term Liabilities
293.73221.9183.26146.1132.19
Total Liabilities
8,0948,40510,70810,7354,688
Common Stock
160.56155.68155.2154.76154.56
Additional Paid-In Capital
-1,6411,134697.02507.68
Retained Earnings
-30,85726,67622,75719,933
Comprehensive Income & Other
41,4321,6791,2681,195745.66
Total Common Equity
41,59234,33329,23324,80421,341
Minority Interest
----44.9
Shareholders' Equity
41,59234,33329,23324,80421,386
Total Liabilities & Equity
49,68642,73839,94135,53926,074
Total Debt
35.89278.93,7775,724545.59
Net Cash (Debt)
8,8124,222819.79-3,03220.92
Net Cash Growth
108.71%415.01%---99.68%
Net Cash Per Share
55.2126.615.17-19.360.14
Filing Date Shares Outstanding
159.64155.68155.19154.76154.56
Total Common Shares Outstanding
159.64155.68155.19154.76154.56
Working Capital
23,18212,9049,8519,7368,694
Book Value Per Share
260.54220.54188.37160.28138.07
Tangible Book Value
28,72720,58714,77411,00614,053
Tangible Book Value Per Share
179.95132.2495.2071.1290.92
Land
-329.41329.415.725.72
Buildings
-3,2343,1112,9252,833
Machinery
-9,6978,7678,3638,095
Construction In Progress
-467633.22444.09139.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.